Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	[heparan sulfate]-glucosamine N-sulfotransferase activity	NDST4 NDST3	7.60e-06	4	23	2	GO:0015016
GeneOntologyMolecularFunction	N-acetylglucosamine deacetylase activity	NDST4 NDST3	7.60e-06	4	23	2	GO:0050119
GeneOntologyMolecularFunction	heparan sulfate sulfotransferase activity	NDST4 NDST3	1.32e-04	15	23	2	GO:0034483
GeneOntologyMolecularFunction	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds	NDST4 NDST3 DCLRE1A	6.09e-04	146	23	3	GO:0016810
GeneOntologyMolecularFunction	deacetylase activity	NDST4 NDST3	9.64e-04	40	23	2	GO:0019213
GeneOntologyMolecularFunction	sulfotransferase activity	NDST4 NDST3	1.82e-03	55	23	2	GO:0008146
GeneOntologyMolecularFunction	transferase activity, transferring sulphur-containing groups	NDST4 NDST3	3.26e-03	74	23	2	GO:0016782
GeneOntologyMolecularFunction	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides	NDST4 NDST3	3.89e-03	81	23	2	GO:0016811
GeneOntologyBiologicalProcess	heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process	NDST4 NDST3	3.32e-05	8	23	2	GO:0015014
GeneOntologyBiologicalProcess	heparin biosynthetic process	NDST4 NDST3	6.50e-05	11	23	2	GO:0030210
GeneOntologyBiologicalProcess	heparin metabolic process	NDST4 NDST3	1.60e-04	17	23	2	GO:0030202
Domain	HSNSD	NDST4 NDST3	8.69e-06	4	23	2	PF12062
Domain	Heparan_SO4_deacetylase	NDST4 NDST3	8.69e-06	4	23	2	IPR021930
Domain	Sulfotransferase_dom	NDST4 NDST3	8.91e-04	36	23	2	IPR000863
Domain	Sulfotransfer_1	NDST4 NDST3	8.91e-04	36	23	2	PF00685
Domain	Homeobox_metazoa	HOXD10 HOXA10	5.44e-03	90	23	2	IPR020479
Pathway	KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_BIOSYNTHESIS	NDST4 NDST3	5.01e-05	11	14	2	M47921
Pathway	KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE	NDST4 NDST3	2.94e-04	26	14	2	M7330
Pathway	REACTOME_HS_GAG_BIOSYNTHESIS	NDST4 NDST3	3.66e-04	29	14	2	MM14802
Pathway	REACTOME_HS_GAG_BIOSYNTHESIS	NDST4 NDST3	4.19e-04	31	14	2	M685
Pathway	WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS	NDST4 NDST3	7.35e-04	41	14	2	M48095
Pathway	REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM	NDST4 NDST3	1.27e-03	54	14	2	MM14633
Pathway	WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM	BRCA2 RIF1	1.32e-03	55	14	2	M39598
Pathway	REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM	NDST4 NDST3	1.42e-03	57	14	2	M692
Pathway	PID_AP1_PATHWAY	CCN1 CXCL8	2.13e-03	70	14	2	M167
Pubmed	Hoxa10 and Hoxd10 coordinately regulate lumbar motor neuron patterning.	HOXD10 HOXA10	4.18e-07	2	23	2	12918017
Pubmed	The paralogous Hox genes Hoxa10 and Hoxd10 interact to pattern the mouse hindlimb peripheral nervous system and skeleton.	HOXD10 HOXA10	1.25e-06	3	23	2	11180954
Pubmed	Hypoxia induces cysteine-rich 61, vascular endothelial growth factor, and interleukin-8 expressions in human nasal polyp fibroblasts: An implication of neutrophils in the pathogenesis of nasal polyposis.	CCN1 CXCL8	1.25e-06	3	23	2	21711965
Pubmed	Functional cooperation between the non-paralogous genes Hoxa-10 and Hoxd-11 in the developing forelimb and axial skeleton.	HOXD10 HOXA10	1.25e-06	3	23	2	8625796
Pubmed	Lowered expression of heparan sulfate/heparin biosynthesis enzyme N-deacetylase/n-sulfotransferase 1 results in increased sulfation of mast cell heparin.	NDST4 NDST3	2.51e-06	4	23	2	22049073
Pubmed	Regulated translation of heparan sulfate N-acetylglucosamine N-deacetylase/n-sulfotransferase isozymes by structured 5'-untranslated regions and internal ribosome entry sites.	NDST4 NDST3	2.51e-06	4	23	2	12070138
Pubmed	Respecification of vertebral identities by retinoic acid.	HOXD10 HOXA10	2.51e-06	4	23	2	1358593
Pubmed	The establishment of murine Hox-1 expression domains during patterning of the limb.	HOXD10 HOXA10	2.51e-06	4	23	2	8099045
Pubmed	Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer.	BRCA2 RIF1	4.18e-06	5	23	2	38244928
Pubmed	Coordinated actions of the forkhead protein Foxp1 and Hox proteins in the columnar organization of spinal motor neurons.	HOXD10 HOXA10	4.18e-06	5	23	2	18667151
Pubmed	Expression patterns of Hox10 paralogous genes during lumbar spinal cord development.	HOXD10 HOXA10	4.18e-06	5	23	2	16495162
Pubmed	Multiple isozymes of heparan sulfate/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase. Structure and activity of the fourth member, NDST4.	NDST4 NDST3	4.18e-06	5	23	2	11087757
Pubmed	Hox10 and Hox11 genes are required to globally pattern the mammalian skeleton.	HOXD10 HOXA10	1.17e-05	8	23	2	12869760
Pubmed	FGF signaling sustains the odontogenic fate of dental mesenchyme by suppressing β-catenin signaling.	NDST4 NDST3	1.17e-05	8	23	2	24067353
Pubmed	Developmental and regional expression of heparan sulfate sulfotransferase genes in the mouse brain.	NDST4 NDST3	2.29e-05	11	23	2	15944372
Pubmed	Recombineering-based dissection of flanking and paralogous Hox gene functions in mouse reproductive tracts.	HOXD10 HOXA10	2.29e-05	11	23	2	23760953
Pubmed	VACTERL/caudal regression/Currarino syndrome-like malformations in mice with mutation in the proprotein convertase Pcsk5.	HOXD10 HOXA10	2.75e-05	12	23	2	18519639
Pubmed	SUMOylation activates large tumour suppressor 1 to maintain the tissue homeostasis during Hippo signalling.	CCN1 BRCA2	2.75e-05	12	23	2	34267330
Pubmed	Variant heparan sulfates synthesized in developing mouse brain differentially regulate FGF signaling.	NDST4 NDST3	2.75e-05	12	23	2	12460940
Pubmed	The cell-cycle regulator geminin inhibits Hox function through direct and polycomb-mediated interactions.	HOXD10 HOXA10	3.25e-05	13	23	2	14973489
Pubmed	Hox gene function in vertebrate gut morphogenesis: the case of the caecum.	HOXD10 HOXA10	3.25e-05	13	23	2	17942481
Pubmed	Development of the Proximal-Anterior Skeletal Elements in the Mouse Hindlimb Is Regulated by a Transcriptional and Signaling Network Controlled by Sall4.	HOXD10 HOXA10	3.79e-05	14	23	2	32156750
Pubmed	Shox2 is required for chondrocyte proliferation and maturation in proximal limb skeleton.	HOXD10 HOXA10	4.37e-05	15	23	2	17481601
Pubmed	Identification of a Hoxd10-regulated transcriptional network and combinatorial interactions with Hoxa10 during spinal cord development.	HOXD10 HOXA10	4.99e-05	16	23	2	14743444
Pubmed	Ezh2 regulates anteroposterior axis specification and proximodistal axis elongation in the developing limb.	HOXD10 HOXA10	4.99e-05	16	23	2	21795281
Pubmed	A Hox Code Defines Spinocerebellar Neuron Subtype Regionalization.	HOXD10 HOXA10	4.99e-05	16	23	2	31747609
Pubmed	Hox patterning of the vertebrate rib cage.	HOXD10 HOXA10	5.66e-05	17	23	2	17626057
Pubmed	Multiple enhancers regulate Hoxd genes and the Hotdog LncRNA during cecum budding.	HOXD10 HOXA10	5.66e-05	17	23	2	24075990
Pubmed	Hoxc10 and Hoxd10 regulate mouse columnar, divisional and motor pool identity of lumbar motoneurons.	HOXD10 HOXA10	5.66e-05	17	23	2	18065432
Pubmed	Gli3 and Plzf cooperate in proximal limb patterning at early stages of limb development.	HOXD10 HOXA10	6.36e-05	18	23	2	16015334
Pubmed	The HOX homeodomain proteins block CBP histone acetyltransferase activity.	HOXD10 HOXA10	6.36e-05	18	23	2	11585930
Pubmed	Misexpression of Pknox2 in mouse limb bud mesenchyme perturbs zeugopod development and deltoid crest formation.	HOXD10 HOXA10	6.36e-05	18	23	2	23717575
Pubmed	Hox10 genes function in kidney development in the differentiation and integration of the cortical stroma.	HOXD10 HOXA10	7.10e-05	19	23	2	21858105
Pubmed	Shox2 regulates progression through chondrogenesis in the mouse proximal limb.	HOXD10 HOXA10	7.10e-05	19	23	2	23038774
Pubmed	Oct4 Is a Key Regulator of Vertebrate Trunk Length Diversity.	HOXD10 HOXA10	7.10e-05	19	23	2	27453501
Pubmed	Heparan sulfate biosynthetic gene Ndst1 is required for FGF signaling in early lens development.	NDST4 NDST3	7.89e-05	20	23	2	17107998
Pubmed	NDST1-dependent heparan sulfate regulates BMP signaling and internalization in lung development.	NDST4 NDST3	9.59e-05	22	23	2	19299468
Pubmed	Pbx1/Pbx2 requirement for distal limb patterning is mediated by the hierarchical control of Hox gene spatial distribution and Shh expression.	HOXD10 HOXA10	1.05e-04	23	23	2	16672333
Pubmed	Sall4-Gli3 system in early limb progenitors is essential for the development of limb skeletal elements.	HOXD10 HOXA10	1.24e-04	25	23	2	25848055
Pubmed	The human HOX gene family.	HOXD10 HOXA10	1.68e-04	29	23	2	2574852
Pubmed	Targeted Disruption of Lats1 and Lats2 in Mice Impairs Testis Development and Alters Somatic Cell Fate.	CALD1 CCN1	1.92e-04	31	23	2	36362374
Pubmed	Ndrg2 regulates vertebral specification in differentiating somites.	HOXD10 HOXA10	2.05e-04	32	23	2	22819676
Pubmed	Sf3b4 regulates chromatin remodeler splicing and Hox expression.	HOXD10 HOXA10	2.05e-04	32	23	2	37167859
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	BRCA2 ATAD5 RIF1 DCLRE1A	2.07e-04	453	23	4	29656893
Pubmed	Genome-wide association scan of dental caries in the permanent dentition.	APBB2 HOXA10	2.18e-04	33	23	2	23259602
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	CCN1 DCLRE1A ANKRD12	2.39e-04	184	23	3	32908313
Pubmed	An approach based on a genome-wide association study reveals candidate loci for narcolepsy.	APBB2 BRCA2 RIF1	2.75e-04	193	23	3	20677014
Pubmed	Atlas of Hox gene expression in the developing kidney.	HOXD10 HOXA10	2.90e-04	38	23	2	15042701
Pubmed	Complete mutation analysis panel of the 39 human HOX genes.	HOXD10 HOXA10	2.90e-04	38	23	2	11857506
Pubmed	Lysine demethylase 7a regulates murine anterior-posterior development by modulating the transcription of Hox gene cluster.	HOXD10 HOXA10	3.05e-04	39	23	2	33257809
Pubmed	Quantification of Hox and surfactant protein-B transcription during murine lung development.	HOXD10 HOXA10	3.21e-04	40	23	2	19204410
Pubmed	Lin28a/let-7 pathway modulates the Hox code via Polycomb regulation during axial patterning in vertebrates.	HOXD10 HOXA10	3.38e-04	41	23	2	32479258
Pubmed	Reduction of Hox gene expression by histone H1 depletion.	HOXD10 HOXA10	3.72e-04	43	23	2	22701719
Pubmed	Nomenclature for human homeobox genes.	HOXD10 HOXA10	3.89e-04	44	23	2	1973146
Pubmed	Vertebrate homeobox gene nomenclature.	HOXD10 HOXA10	4.44e-04	47	23	2	1358459
Pubmed	Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer.	BRCA2 CXCL8	4.83e-04	49	23	2	19012493
Pubmed	New insights into the role of Jmjd3 and Utx in axial skeletal formation in mice.	HOXD10 HOXA10	5.03e-04	50	23	2	28188179
Pubmed	High-resolution gene expression analysis of the developing mouse kidney defines novel cellular compartments within the nephron progenitor population.	HOXD10 HOXA10	6.30e-04	56	23	2	19591821
Interaction	NDST4 interactions	NDST4 NDST3	3.47e-05	8	23	2	int:NDST4
Interaction	NDST3 interactions	NDST4 NDST3	4.46e-05	9	23	2	int:NDST3
Interaction	ERCC6 interactions	BRCA2 RIF1 DCLRE1A ZBTB38	1.11e-04	224	23	4	int:ERCC6
Interaction	EN2 interactions	HOXD10 HOXA10	1.12e-04	14	23	2	int:EN2
Interaction	ASF1A interactions	CALD1 BRCA2 ATAD5 RIF1	1.67e-04	249	23	4	int:ASF1A
Cytoband	4q26	NDST4 NDST3	2.24e-04	44	23	2	4q26
Cytoband	Ensembl 112 genes in cytogenetic band chr4q26	NDST4 NDST3	3.51e-04	55	23	2	chr4q26
Cytoband	Ensembl 112 genes in cytogenetic band chr4q13	CXCL8 SLC4A4	2.80e-03	157	23	2	chr4q13
GeneFamily	Sulfotransferases, membrane bound	NDST4 NDST3	5.44e-04	37	17	2	763
GeneFamily	HOXL subclass homeoboxes	HOXD10 HOXA10	1.07e-03	52	17	2	518
Coexpression	AMIT_EGF_RESPONSE_60_MCF10A	CALD1 CCN1 CXCL8	5.28e-06	39	23	3	M6815
Coexpression	AMIT_SERUM_RESPONSE_60_MCF10A	CALD1 CCN1 CXCL8	1.76e-05	58	23	3	M3447
Coexpression	KIM_WT1_TARGETS_12HR_DN	CALD1 CCN1 APBB2 HOXA10	3.51e-05	216	23	4	M4987
Coexpression	NUYTTEN_NIPP1_TARGETS_UP	CALD1 ZNF215 CXCL8 PARP12 HHIPL2 SLC4A4	4.09e-05	768	23	6	M6444
Coexpression	LAKE_ADULT_KIDNEY_C28_INTERSTITIUM	CALD1 CCN1 APBB2	5.76e-05	86	23	3	M39247
Coexpression	WINZEN_DEGRADED_VIA_KHSRP	CCN1 CXCL8 SLC4A4	9.03e-05	100	23	3	M2352
Coexpression	CHIBA_RESPONSE_TO_TSA_DN	BRCA2 CXCL8	1.53e-04	21	23	2	M12459
CoexpressionAtlas	JC_hmvEC_top-relative-expression-ranked_1000	CCN1 NDST3 HOXD10 HOXA10 SPINK7 ZNF366 CXCL8 PARP12	5.69e-06	990	23	8	JC_hmvEC_1000
CoexpressionAtlas	JC_hmvEC_top-relative-expression-ranked_1000_k-means-cluster#4	CCN1 NDST3 HOXD10 ZNF366 PARP12	8.10e-05	428	23	5	JC_hmvEC_1000_K4
CoexpressionAtlas	kidney_adult_Mesangium_Meis_top-relative-expression-ranked_500	CALD1 APBB2 ANKRD12 PARP12 HCAR1	8.19e-05	429	23	5	gudmap_kidney_adult_Mesangium_Meis_500
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000	CALD1 CCN1 HOXD10 SLC4A4	1.74e-04	265	23	4	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000
CoexpressionAtlas	kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000	CALD1 APBB2 ANKRD12 ZBTB38 PARP12 HCAR1	2.61e-04	872	23	6	gudmap_kidney_adult_Mesangium_Meis_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K2	CCN1 IFNLR1 CXCL8	2.73e-04	118	23	3	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K2
CoexpressionAtlas	kidney_adult_CortVasc_Tie2_k-means-cluster#4_top-relative-expression-ranked_1000	CALD1 APBB2 PARP12	4.32e-04	138	23	3	gudmap_kidney_adult_CortVasc_Tie2_k4_1000
CoexpressionAtlas	kidney_adult_Podocyte_MafB_k-means-cluster#2_top-relative-expression-ranked_1000	APBB2 ANKRD12 PARP12	4.70e-04	142	23	3	gudmap_kidney_adult_Podocyte_MafB_k2_1000
CoexpressionAtlas	kidney_adult_Mesangium_Meis_k-means-cluster#2_top-relative-expression-ranked_1000	CALD1 APBB2 ZBTB38 HCAR1	4.91e-04	348	23	4	gudmap_kidney_adult_Mesangium_Meis_k2_1000
CoexpressionAtlas	Progenitor-Cell-Biology-Consortium_reference_PulmonMicrovasc_top-relative-expression-ranked_1000	CCN1 HOXD10 HOXA10 ZNF366 CXCL8 PARP12	4.91e-04	981	23	6	PCBC_ctl_PulmonMicrovasc_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500	CALD1 CCN1 SLC4A4	5.10e-04	146	23	3	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500
CoexpressionAtlas	kidney_adult_RenCorpuscGlomer_k-means-cluster#4_top-relative-expression-ranked_1000	CALD1 APBB2 HCAR1	5.30e-04	148	23	3	gudmap_kidney_adult_RenCorpuscGlomer_k4_1000
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NDST4 HOXD10 HOXA10 SLC4A4	9.74e-07	149	23	4	aedbae2dffa1e880e5c6a146b6d5a135e7f54308
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NDST4 HOXD10 HOXA10 SLC4A4	1.50e-06	166	23	4	3b67064a5149e72f895344d938c64b8ff65247f5
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CALD1 CCN1 HOXD10 HOXA10	2.16e-06	182	23	4	728a2152c166551ac229370c0900fe2bc426ea9b
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CALD1 HOXD10 HOXA10 SLC4A4	2.35e-06	186	23	4	8ea708070166c858cd9bd871670655b0114c32a5
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CALD1 NDST4 HOXD10 HOXA10	2.41e-06	187	23	4	39756ab418267151d86f9c2553db859f71900bb1
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CCN1 CXCL8 HCAR1 SLC4A4	2.90e-06	196	23	4	cdc89eb6a9c3811dc4fd15e73f596299a61326ee
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CCN1 CXCL8 HCAR1 SLC4A4	2.90e-06	196	23	4	50436ddc61e4ab8df055a527e7514aaaaf6e90ee
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CCN1 CXCL8 HCAR1 SLC4A4	2.90e-06	196	23	4	1b3a191749cf143d35f7f73cf0e239535ece0ca7
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CCN1 CXCL8 HCAR1 SLC4A4	2.90e-06	196	23	4	0d83501e580de523aac073709395ed7b889e0bb2
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CALD1 NDST4 HOXA10 SLC4A4	2.96e-06	197	23	4	ea746772adb9df4ddb0508d4ef35f2027bf09c35
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CALD1 CCN1 HOXD10 HOXA10	2.96e-06	197	23	4	ad6c200a193a15360d17463e18a465ce1b90b8da
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CALD1 CCN1 HOXD10 HOXA10	2.96e-06	197	23	4	fc718a254bda4df2d62975d04393492fb75ab305
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CALD1 CCN1 HOXD10 HOXA10	2.96e-06	197	23	4	c7b33d64e5cba3a8fc6f2d6aa85ebc83893195de
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CALD1 CCN1 HOXD10 HOXA10	3.08e-06	199	23	4	3d8c76e3d05acf72a35ca755b51579fc3ae63562
ToppCell	(03)_KRT6B+\|World / shred by cell type by condition	CALD1 CCN1 ZBTB38 CXCL8	3.08e-06	199	23	4	9feaf8649b3f68f30b8cb6b045a2caa2dd343c7f
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NDST4 HOXD10 HOXA10	5.65e-05	146	23	3	669001b772b6d6109a09727619ed5829122b48db
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NDST4 NDST3 HOXA10	7.01e-05	157	23	3	beab0ac47202266b04543c02cfcdda012375e879
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM5-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CCN1 SPINK7 CXCL8	8.27e-05	166	23	3	006ced12f69ef13ddcba5a3891ddc7c18c384863
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM5\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CCN1 SPINK7 CXCL8	8.27e-05	166	23	3	ac28c8cac1e94be0c47fb862c5809c92cdaa11f3
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM5-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CCN1 SPINK7 CXCL8	8.27e-05	166	23	3	6bb3410e65c971acc458c472015afcec6de6e310
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM5\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	CCN1 SPINK7 CXCL8	8.27e-05	166	23	3	823ec03714884cb860a1260410feac8c536b6d06
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 ATAD5 DCLRE1A	8.42e-05	167	23	3	108ae6221c6edc63c0ec42c42471b3a15a594043
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 ATAD5 ZNF366	8.42e-05	167	23	3	bc132b51dec4e8f1cd2b2cd89f83641976e09292
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CALD1 HOXA10 CCDC116	8.72e-05	169	23	3	3f738fc56bbc70dc77c9ba41025631f8264cd2b3
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CCN1 CXCL8 SLC4A4	9.19e-05	172	23	3	5401ac7739f95fb8681cfb4747ab6e447a3c2ae8
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CCN1 CXCL8 SLC4A4	9.19e-05	172	23	3	b3da7f488d191214d7bb74fbac189fe8c29ee6cd
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CCN1 CXCL8 SLC4A4	9.19e-05	172	23	3	74dd4a7acb2cf857fed20219e4d7dc1adfbaa398
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CALD1 APBB2 ZNF366	9.51e-05	174	23	3	18ab52d8bbca0507fee220e0c4fc765fc47dda34
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NDST3 HOXA10 ANKRD12	9.67e-05	175	23	3	65571d775d26a40e979dbf290a8e4320c0d9fb3f
ToppCell	COVID-matDC-\|COVID / Condition, Cell_class and T cell subcluster	CALD1 HOXA10 ZNF366	9.67e-05	175	23	3	db5e170411dfa62074c4b8311bb8c589d1c4279b
ToppCell	COVID-matDC\|COVID / Condition, Cell_class and T cell subcluster	CALD1 HOXA10 ZNF366	9.67e-05	175	23	3	e2b638109c9ffd10430e6e134035622b7605ce23
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CALD1 CCN1 CCDC116	1.00e-04	177	23	3	b872ee91e01265b101b81bd304cf6b95d5419e68
ToppCell	tumor_Lung-Endothelial_cells-EPCs\|tumor_Lung / Location, Cell class and cell subclass	HOXD10 ZNF366 CCDC116	1.00e-04	177	23	3	f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5
ToppCell	COVID-19_Convalescent-Classical_Monocyte-cMono_4\|COVID-19_Convalescent / Disease condition and Cell class	CALD1 APBB2 ATAD5	1.03e-04	179	23	3	366e4a31db9e80fd1770ac9f1ae148fefeb9f7df
ToppCell	COVID-19_Convalescent-Classical_Monocyte-cMono_4\|Classical_Monocyte / Disease condition and Cell class	CALD1 APBB2 ATAD5	1.03e-04	179	23	3	9d51318ac198a8801bd5c7031ebf2b0c74ffeeb6
ToppCell	LPS-IL1RA-Endothelial-Endothelial-FOXM1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BRCA2 ATAD5 SPINK7	1.05e-04	180	23	3	334e2b1f6eb7d4ece20b1c7b02107863f913237f
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CALD1 NDST4 SLC4A4	1.07e-04	181	23	3	d7e04e0ca549eac6d9b1192b6578f9b54943d54f
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CALD1 NDST4 CCN1	1.09e-04	182	23	3	3dfa9187e9d2bab1d199079d29209c4648220ada
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CALD1 CCN1 NDST3	1.10e-04	183	23	3	b4f29dd3994009bb5eb769d36d95886664e7f87d
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	RIF1 CXCL8 PARP12	1.10e-04	183	23	3	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CALD1 NDST3 SLC4A4	1.10e-04	183	23	3	12daaea821e49bc94a01e2496331e92a80d27339
ToppCell	B_cells-ISG-high_B_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	CALD1 BRCA2 PARP12	1.10e-04	183	23	3	dc2b00e920efa1dcc2a6265cd1024e3249c9974f
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-2\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CALD1 IFNLR1 HHIPL2	1.14e-04	185	23	3	502361b041a036de024eb5fe378ca09fac9b67ee
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CALD1 CCN1 APBB2	1.14e-04	185	23	3	35d39a1d04c871edcfb749653538dc5fd0054281
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CALD1 NDST4 HOXA10	1.16e-04	186	23	3	360c3e9e5c3a943e68e6939b4a47821bfc75b553
ToppCell	Mesenchymal_cells-Adipo-CAR\|World / Lineage and Cell class	CALD1 CCN1 APBB2	1.16e-04	186	23	3	6ca8ce7ced91d6308b7c056032ffec1b37c974bf
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 HOXA10 ATAD5	1.18e-04	187	23	3	e41e39fd3791acf8ae5376cc5061e196d96868ae
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 HOXA10 ATAD5	1.18e-04	187	23	3	cefa211ef224e803ea9467882e2ca74d0b1492f1
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	CALD1 CCN1 APBB2	1.18e-04	187	23	3	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	COVID-19-kidney-Fibroblast-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CALD1 CCN1 HOXD10	1.18e-04	187	23	3	76bfe8c42430a230a8bdf299575c444fb7780f24
ToppCell	390C-Endothelial_cells-Endothelial-D-\|390C / Donor, Lineage, Cell class and subclass (all cells)	CALD1 CCN1 ZNF366	1.20e-04	188	23	3	50481192da0e9484accb7fcbf9e28a246bb3b80f
ToppCell	390C-Endothelial_cells-Endothelial-D\|390C / Donor, Lineage, Cell class and subclass (all cells)	CALD1 CCN1 ZNF366	1.20e-04	188	23	3	30bbd00297de7a2e3e6008aaf37ec0d0617315eb
ToppCell	droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte-2\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CALD1 HOXA10 IFNLR1	1.20e-04	188	23	3	c300accbac71a3bc075fe985543d8a8ead82531b
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CALD1 NDST3 SLC4A4	1.21e-04	189	23	3	b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CALD1 NDST3 SLC4A4	1.21e-04	189	23	3	f75cebd4c3e54e297557449ba67ccc8d1a2a14f5
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CALD1 CCN1 NDST3	1.23e-04	190	23	3	7df63e5e0dd395676f4fc18cad0d8b2428390943
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CALD1 CCN1 HOXA10	1.23e-04	190	23	3	c01a8bfb9fbc0e6f37d7e9be25512eda63acabbc
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CALD1 CCN1 NDST3	1.23e-04	190	23	3	140aca04c044cd7a93f81ff1631b00b5216d2cb1
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	BRCA2 NDST3 ATAD5	1.23e-04	190	23	3	e83fa8b711aa79a1767818474f1c193b674b1c31
ToppCell	(1)_Control_(PBS)-(3)_LEPR+_perivascular_cells\|World / Stress and Cell class	CALD1 APBB2 HOXA10	1.23e-04	190	23	3	ec0ab31266583a0966ac7615d5c0fabb7b7e66e8
ToppCell	PBMC-Severe-cDC_12\|Severe / Compartment, Disease Groups and Clusters	BRCA2 ATAD5 RIF1	1.23e-04	190	23	3	84ee185939bdefb10705b621a70da27701eadcee
ToppCell	18-Airway-Mesenchymal-Airway_Smooth_Muscle\|Airway / Age, Tissue, Lineage and Cell class	CALD1 NDST4 SLC4A4	1.25e-04	191	23	3	86ce98d2c90c196474b06869de888cf5d1eed196
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CALD1 CCN1 NDST3	1.25e-04	191	23	3	9431ffd6b758f756609d9057de2023596e22b5d4
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_ductal_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CALD1 CCN1 DCLRE1A	1.27e-04	192	23	3	f3133bbbf938a39062a9b1d1181003bb48174695
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CALD1 CCN1 HOXA10	1.27e-04	192	23	3	d0fb6885f023d55a2b7984c99db9c6463258f788
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NDST4 NDST3 SLC4A4	1.27e-04	192	23	3	72881b280a415e65f87a80ca1369cbb0b722a0c4
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CALD1 CCN1 HOXA10	1.27e-04	192	23	3	f345b269c8cf06b004bc9419462dbc69bffaab89
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CALD1 CCN1 HOXA10	1.29e-04	193	23	3	4aa976b596830b585e8d9c808d5072ed23d13a7c
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CALD1 HOXD10 HOXA10	1.29e-04	193	23	3	68089ba4123e2f9bea9aae0023a844b5a57bfc0e
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_ductal_cel\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CALD1 CCN1 DCLRE1A	1.29e-04	193	23	3	c13e2612330ca8b9a8c206e588b26025c4f5898c
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CALD1 CCN1 HOXA10	1.29e-04	193	23	3	5578f7cb3ec68c9a38cc5304b618b81283024d5e
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CALD1 HOXD10 HOXA10	1.29e-04	193	23	3	164cc8d51a67c2df3112338acbb1f93c5f838376
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	NDST4 BRCA2 NDST3	1.29e-04	193	23	3	bbdfda6665941cfa1965418bb91ef9ff43b1326f
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CALD1 CCN1 HOXA10	1.29e-04	193	23	3	0256e8fe4a47f2e2a43ef9d19bfc047d20806d69
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CALD1 CCN1 HHIPL2	1.29e-04	193	23	3	5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CALD1 NDST3 SLC4A4	1.29e-04	193	23	3	2f203f6f0c2135acb046c9351a633c3b5b254a46
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	CCN1 APBB2 SLC4A4	1.31e-04	194	23	3	7c6c0376603e5fcb64814fd6204d153629c2fbf5
ToppCell	cellseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CXCL8 HCAR1 SLC4A4	1.31e-04	194	23	3	5402835d6b252276e458001949dd1cb5aa744b0e
ToppCell	cellseq-Epithelial-Epithelial_Airway-Secretory/RAS\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CXCL8 HCAR1 SLC4A4	1.31e-04	194	23	3	2c0236a102f7fec6d508afec6137da5b26a65931
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	NDST4 NDST3 SLC4A4	1.31e-04	194	23	3	67f5e2f05a8de2213ab80d5ea16fdee121684633
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	BRCA2 NDST3 ATAD5	1.31e-04	194	23	3	590a9d4f054e6a3685daf752c9354650fcc7d18a
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CALD1 CCN1 SLC4A4	1.31e-04	194	23	3	08fad7591c20568de797cf8e206de2d0b1d78aab
ToppCell	356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	HOXA10 ATAD5 CXCL8	1.33e-04	195	23	3	751cb00b0f3005be6b645adadfbb9dd2215b6e08
ToppCell	(0)_NK_cells-(0)_NK_CD160pos\|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	HOXA10 ZBTB38 SLC4A4	1.33e-04	195	23	3	6cbeceb52bb207f3c074e57b5b3f7cfb24fd5877
ToppCell	COVID-19-kidney-Fibroblast-2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CALD1 CCN1 HOXD10	1.33e-04	195	23	3	3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2
ToppCell	5'-GW_trimst-2-LargeIntestine\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HOXD10 HOXA10 SLC4A4	1.33e-04	195	23	3	1a4a5623fa0318ef388cc228c7060e0586a7acf9
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CCN1 HOXD10 HOXA10	1.35e-04	196	23	3	fd0a2b863dedaf08d18e7f67da18ac7e853991e4
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CALD1 HOXD10 HOXA10	1.35e-04	196	23	3	a7adc0e0baef261d0937e4e8351321d41beca82f
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CALD1 CCN1 APBB2	1.35e-04	196	23	3	2b36b9a40fe415917afccff99ad9c3474e087d0d
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	CALD1 CCN1 APBB2	1.37e-04	197	23	3	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CALD1 CCN1 APBB2	1.37e-04	197	23	3	85a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCell	Healthy-T/NK_proliferative\|World / disease group, cell group and cell class	CCN1 BRCA2 ATAD5	1.37e-04	197	23	3	e90be1e7e02f736b6aab14010a912b592d6f1e80
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CCN1 HOXD10 HOXA10	1.37e-04	197	23	3	2a90422ba400b951517603a916f34221056d0f3d
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CALD1 CCN1 APBB2	1.37e-04	197	23	3	80e153790cef37b743e22a7370ff5b3a6abf147d
ToppCell	5'-GW_trimst-1.5-LargeIntestine\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CCN1 HOXD10 HOXA10	1.37e-04	197	23	3	0b2ad6a933ff1a325649cc8f139380fd158a1d42
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CALD1 CCN1 APBB2	1.37e-04	197	23	3	e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CCN1 HOXD10 HOXA10	1.37e-04	197	23	3	5f6fce382f273e789ffbb75b63e9b4e87519918e
ToppCell	distal-1-Epithelial-Basal\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	HOXD10 SPINK7 CXCL8	1.37e-04	197	23	3	25a2ccc98b973611de0d920b1b455d0b40f0d37f
ToppCell	Non-neuronal-Dividing-IPC-IPC-new\|World / Primary Cells by Cluster	CALD1 CCN1 BRCA2	1.39e-04	198	23	3	11d2d4d179bc31ef2897d7ceeaf9bed1b20cbdc0
ToppCell	Non-neuronal-Dividing-IPC-IPC-new-9\|World / Primary Cells by Cluster	CALD1 CCN1 BRCA2	1.39e-04	198	23	3	c724ef958e14e17a7d8c02b9f842510c0780f635
Computational	Genes upregulated in subsets of cells of a given type within various tumors	ANKRD12 ZBTB38	1.54e-03	49	13	2	GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED
Computational	Genes upregulated in subsets of cells of a given type within various tumors	CCN1 CXCL8	1.60e-03	50	13	2	GAVISH_3CA_MALIGNANT_METAPROGRAM_22_SECRETED_1
Computational	Genes upregulated in subsets of cells of a given type within various tumors	CALD1 CCN1	1.60e-03	50	13	2	GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_1
Computational	Genes upregulated in subsets of cells of a given type within various tumors	CALD1 CCN1	1.60e-03	50	13	2	GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1
Computational	Genes upregulated in subsets of cells of a given type within various tumors	CCN1 CXCL8	1.60e-03	50	13	2	GAVISH_3CA_METAPROGRAM_EPITHELIAL_STRESS
Computational	Genes upregulated in subsets of cells of a given type within various tumors	ATAD5 RIF1	1.60e-03	50	13	2	GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN
Drug	pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A	CCN1 APBB2 BRCA2 DCLRE1A ZBTB38 CXCL8	2.24e-08	183	23	6	7088_DN
Drug	Catechin-(+,-) hydrate [7295-85-4]; Down 200; 13.8uM; HL60; HT_HG-U133A	APBB2 HOXD10 HOXA10 ZNF215 PARP12	1.40e-06	198	23	5	3012_DN
Drug	Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; HL60; HT_HG-U133A	CALD1 CCN1 HOXA10 RIF1 ZBTB38	1.40e-06	198	23	5	2549_UP
Drug	I Qa	CXCL8 SLC4A4	2.04e-05	7	23	2	CID000447682
Drug	1-ephedrine	CCN1 BRCA2 SLC4A4	2.82e-05	59	23	3	CID000005032
Drug	Podophyllotoxin [518-28-5]; Up 200; 9.6uM; PC3; HT_HG-U133A	CCN1 ANKRD12 CXCL8 SLC4A4	3.45e-05	187	23	4	5841_UP
Drug	Triprolidine hydrochloride [550-70-9]; Up 200; 12.8uM; PC3; HT_HG-U133A	CCN1 RIF1 CXCL8 PARP12	3.83e-05	192	23	4	7248_UP
Drug	pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A	CALD1 CCN1 ZBTB38 CXCL8	3.83e-05	192	23	4	5930_DN
Drug	2-propylpentanoic acid; Up 200; 1000uM; PC3; HT_HG-U133A	CALD1 APBB2 ATAD5 HHIPL2	3.83e-05	192	23	4	1209_UP
Drug	Pipemidic acid [51940-44-4]; Down 200; 13.2uM; PC3; HT_HG-U133A	BRCA2 ATAD5 ZNF215 CXCL8	3.83e-05	192	23	4	6752_DN
Drug	troglitazone; Down 200; 10uM; PC3; HG-U133A	CCN1 DCLRE1A ANKRD12 CXCL8	3.91e-05	193	23	4	462_DN
Drug	Sertaconazole nitrate [99592-39-9]; Down 200; 8uM; HL60; HT_HG-U133A	APBB2 ZBTB38 CXCL8 SLC4A4	3.99e-05	194	23	4	6128_DN
Drug	Talampicillin hydrochloride [39878-70-1]; Up 200; 7.8uM; PC3; HT_HG-U133A	CALD1 BRCA2 ATAD5 SLC4A4	4.07e-05	195	23	4	7254_UP
Drug	(-)-depudecin; Up 200; 1uM; MCF7; HT_HG-U133A_EA	CALD1 APBB2 ANKRD12 CXCL8	4.07e-05	195	23	4	874_UP
Drug	Mifepristone [84371-65-3]; Down 200; 9.4uM; PC3; HT_HG-U133A	CCN1 HOXA10 DCLRE1A CXCL8	4.15e-05	196	23	4	5827_DN
Drug	rotenone; Up 200; 1uM; MCF7; HT_HG-U133A	HOXA10 RIF1 CXCL8 SLC4A4	4.23e-05	197	23	4	5915_UP
Drug	(+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; PC3; HT_HG-U133A	CALD1 CCN1 ATAD5 ZNF215	4.23e-05	197	23	4	6663_DN
Drug	Hydroflumethiazide [135-09-1]; Down 200; 12uM; MCF7; HT_HG-U133A	CCN1 APBB2 ATAD5 ANKRD12	4.23e-05	197	23	4	7019_DN
Drug	Trimethobenzamide hydrochloride [554-92-7]; Up 200; 9.4uM; PC3; HT_HG-U133A	CALD1 ATAD5 RIF1 SLC4A4	4.23e-05	197	23	4	4100_UP
Drug	copper(II) sulfate pentahydrate; Up 200; 100uM; PC3; HG-U133A	CCN1 HOXA10 ANKRD12 CXCL8	4.32e-05	198	23	4	459_UP
Drug	Sulfamethizole [144-82-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A	CALD1 RIF1 ANKRD12 SLC4A4	4.40e-05	199	23	4	6272_UP
Drug	Glipizide [29094-61-9]; Down 200; 9uM; PC3; HT_HG-U133A	CALD1 BRCA2 ZNF215 SLC4A4	4.40e-05	199	23	4	6645_DN
Drug	DNA-PK Inhibitor III; Down 200; 1uM; PC3; HT_HG-U133A	CALD1 APBB2 RIF1 CXCL8	4.40e-05	199	23	4	7548_DN
Drug	mitomycin C	BRCA2 RIF1 DCLRE1A CXCL8	9.26e-05	241	23	4	CID000005746
Drug	PL-V	DCLRE1A CXCL8	1.83e-04	20	23	2	CID000447949
Drug	Chloroprene	CALD1 CCN1 APBB2 RIF1 ANKRD12 PARP12 SLC4A4	2.66e-04	1348	23	7	ctd:D002737
Drug	torcetrapib	CALD1 CCN1 APBB2 RIF1	3.53e-04	342	23	4	ctd:C483909
Drug	AC1NNI5R	CXCL8 SLC4A4	3.63e-04	28	23	2	CID000504670
Drug	Azaguanine-8 [134-58-7]; Up 200; 26.2uM; PC3; HT_HG-U133A	CALD1 CCN1 CXCL8	5.24e-04	158	23	3	1791_UP
Drug	n-tetradecane	CCN1 CXCL8	5.69e-04	35	23	2	ctd:C024713
Drug	Helveticoside [630-64-8]; Up 200; 7.4uM; PC3; HT_HG-U133A	CCN1 ANKRD12 CXCL8	6.05e-04	166	23	3	4327_UP
Drug	15d-PGJ2; Up 200; 10uM; HL60; HT_HG-U133A	HOXA10 ZBTB38 CXCL8	6.38e-04	169	23	3	2691_UP
Drug	5255229; Up 200; 13uM; MCF7; HT_HG-U133A_EA	CCN1 CXCL8 PARP12	6.83e-04	173	23	3	949_UP
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	HOXA10 DCLRE1A PARP12	6.94e-04	174	23	3	7105_DN
Drug	Zardaverine [101975-10-4]; Up 200; 15uM; HL60; HT_HG-U133A	CCN1 APBB2 ZBTB38	7.18e-04	176	23	3	2926_UP
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	HOXA10 ZBTB38 PARP12	7.18e-04	176	23	3	6546_DN
Drug	thioridazine hydrochloride; Up 200; 10uM; PC3; HT_HG-U133A	CCN1 ATAD5 CXCL8	7.30e-04	177	23	3	1230_UP
Drug	Anthralin	RIF1 CXCL8	7.44e-04	40	23	2	ctd:D000875
Drug	Diethylstilbestrol [56-53-1]; Up 200; 15uM; MCF7; HT_HG-U133A	CCN1 HOXA10 CXCL8	7.54e-04	179	23	3	3895_UP
Drug	prochlorperazine dimaleate salt; Up 200; 10uM; HL60; HT_HG-U133A	APBB2 HOXA10 CXCL8	7.78e-04	181	23	3	2675_UP
Drug	Thioridazine hydrochloride [130-61-0]; Up 200; 9.8uM; PC3; HG-U133A	APBB2 ANKRD12 CXCL8	7.91e-04	182	23	3	1905_UP
Drug	STOCK1N-35215; Up 200; 10uM; PC3; HT_HG-U133A	CALD1 CCN1 CXCL8	7.91e-04	182	23	3	6427_UP
Drug	17-AAG; Up 200; 1uM; HL60; HT_HG-U133A	HOXA10 ZBTB38 SLC4A4	8.04e-04	183	23	3	6185_UP
Drug	17-AAG; Up 200; 1uM; HL60; HT_HG-U133A	CALD1 HOXD10 ZBTB38	8.16e-04	184	23	3	2686_UP
Drug	Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A	BRCA2 ANKRD12 ZBTB38	8.29e-04	185	23	3	1673_DN
Drug	Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A	CCN1 APBB2 PARP12	8.29e-04	185	23	3	4707_UP
Drug	Chloropyramine hydrochloride [6170-42-9]; Up 200; 12.2uM; PC3; HT_HG-U133A	CCN1 CXCL8 SLC4A4	8.55e-04	187	23	3	4589_UP
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A	CCN1 APBB2 SLC4A4	8.69e-04	188	23	3	1667_UP
Drug	Hesperetin [520-33-2]; Down 200; 13.2uM; PC3; HT_HG-U133A	BRCA2 ATAD5 CXCL8	8.82e-04	189	23	3	6750_DN
Drug	DNCB	IFNLR1 CXCL8 SLC4A4	8.82e-04	189	23	3	CID000000006
Drug	troglitazone; Down 200; 10uM; PC3; HT_HG-U133A	CCN1 BRCA2 ZBTB38	8.82e-04	189	23	3	1232_DN
Drug	Alprostadil [745-65-3]; Up 200; 11.2uM; PC3; HT_HG-U133A	ATAD5 RIF1 CXCL8	8.82e-04	189	23	3	4099_UP
Drug	Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A	CALD1 APBB2 CXCL8	8.82e-04	189	23	3	5084_DN
Drug	Loxapine succinate [27833-64-3]; Up 200; 9uM; PC3; HT_HG-U133A	CCN1 CXCL8 SLC4A4	8.82e-04	189	23	3	6694_UP
Drug	troglitazone; Up 200; 10uM; PC3; HG-U133A	APBB2 HHIPL2 SLC4A4	8.96e-04	190	23	3	462_UP
Drug	Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A	APBB2 ATAD5 SLC4A4	8.96e-04	190	23	3	4507_DN
Drug	Leflunomide [75706-12-6]; Up 200; 14.8uM; HL60; HT_HG-U133A	CALD1 ZBTB38 SLC4A4	8.96e-04	190	23	3	2539_UP
Drug	Nocodazole [31430-18-9]; Up 200; 13.2uM; PC3; HT_HG-U133A	CCN1 BRCA2 CXCL8	8.96e-04	190	23	3	7145_UP
Drug	Mitoxantrone dihydrochloride [70476-82-3]; Up 200; 7.8uM; MCF7; HT_HG-U133A	CALD1 RIF1 CXCL8	8.96e-04	190	23	3	3232_UP
Drug	pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A	CALD1 CCN1 CXCL8	8.96e-04	190	23	3	7528_DN
Drug	Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A	CALD1 ATAD5 ZBTB38	8.96e-04	190	23	3	4306_DN
Drug	Clomipramine hydrochloride [17321-77-6]; Up 200; 11.4uM; PC3; HT_HG-U133A	CCN1 HOXD10 CXCL8	9.09e-04	191	23	3	4487_UP
Drug	Colchicine [64-86-8]; Up 200; 10uM; PC3; HT_HG-U133A	CCN1 ATAD5 CXCL8	9.09e-04	191	23	3	4614_UP
Drug	Hexetidine [141-94-6]; Up 200; 11.8uM; PC3; HT_HG-U133A	CALD1 RIF1 CXCL8	9.09e-04	191	23	3	6319_UP
Drug	Propoxycaine hydrochloride [550-83-4]; Down 200; 12uM; PC3; HT_HG-U133A	APBB2 DCLRE1A SLC4A4	9.23e-04	192	23	3	7155_DN
Drug	17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	CCN1 BRCA2 ANKRD12	9.23e-04	192	23	3	993_DN
Drug	Methiothepin maleate [19728-88-2]; Up 200; 8.4uM; HL60; HG-U133A	APBB2 BRCA2 ANKRD12	9.23e-04	192	23	3	1616_UP
Drug	Idoxuridine [54-42-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A	APBB2 PARP12 SLC4A4	9.37e-04	193	23	3	1480_UP
Drug	Tetrahydroalstonine [6474-90-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A	ATAD5 RIF1 DCLRE1A	9.37e-04	193	23	3	6209_UP
Drug	thioridazine hydrochloride; Up 200; 10uM; HL60; HT_HG-U133A	CCN1 APBB2 SLC4A4	9.37e-04	193	23	3	6189_UP
Drug	Antimycin A [1397-94-0]; Down 200; 7.2uM; PC3; HT_HG-U133A	APBB2 DCLRE1A ZNF215	9.37e-04	193	23	3	2098_DN
Drug	Fluvastatin sodium salt [93957-55-2]; Down 200; 9.2uM; PC3; HT_HG-U133A	CCN1 RIF1 CXCL8	9.37e-04	193	23	3	6691_DN
Drug	Cetirizine dihydrochloride [83881-52-1]; Up 200; 8.6uM; MCF7; HT_HG-U133A	APBB2 HOXA10 SLC4A4	9.37e-04	193	23	3	2829_UP
Drug	Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A	CCN1 RIF1 ZBTB38	9.37e-04	193	23	3	4406_DN
Drug	Glycocholic acid [475-31-0]; Down 200; 8.6uM; PC3; HT_HG-U133A	BRCA2 ATAD5 ZNF215	9.37e-04	193	23	3	6716_DN
Drug	Fenbufen [36330-85-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A	CALD1 NDST3 CXCL8	9.37e-04	193	23	3	4743_UP
Drug	Pyrithyldione [77-04-3]; Down 200; 24uM; PC3; HT_HG-U133A	CALD1 APBB2 SLC4A4	9.37e-04	193	23	3	7153_DN
Drug	Nifedipine [21829-25-4]; Up 200; 11.6uM; PC3; HT_HG-U133A	HOXA10 RIF1 CXCL8	9.51e-04	194	23	3	1814_UP
Drug	Skimmianine [83-95-4]; Up 200; 15.4uM; HL60; HT_HG-U133A	CALD1 CCN1 APBB2	9.51e-04	194	23	3	2504_UP
Drug	Capsaicin [404-86-4]; Down 200; 13uM; PC3; HT_HG-U133A	CCN1 BRCA2 DCLRE1A	9.51e-04	194	23	3	4612_DN
Drug	Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; HL60; HT_HG-U133A	APBB2 HOXA10 SLC4A4	9.51e-04	194	23	3	2430_DN
Drug	catechin; Up 200; 11uM; MCF7; HT_HG-U133A_EA	APBB2 ATAD5 ZBTB38	9.51e-04	194	23	3	1101_UP
Drug	Felodipine [72509-76-3]; Down 200; 10.4uM; PC3; HT_HG-U133A	BRCA2 RIF1 SLC4A4	9.51e-04	194	23	3	6695_DN
Drug	Glimepiride [93479-97-1]; Up 200; 8.2uM; PC3; HT_HG-U133A	ATAD5 RIF1 HHIPL2	9.51e-04	194	23	3	6628_UP
Drug	Isradipine [75695-93-1]; Down 200; 10.8uM; PC3; HT_HG-U133A	BRCA2 DCLRE1A SLC4A4	9.51e-04	194	23	3	6347_DN
Drug	Dinoprost trometamol [38362-01-5]; Up 200; 8.4uM; PC3; HT_HG-U133A	RIF1 CXCL8 SLC4A4	9.51e-04	194	23	3	6308_UP
Drug	17-DMAG; Up 200; 0.1uM; PC3; HT_HG-U133A	CALD1 HHIPL2 SLC4A4	9.51e-04	194	23	3	1213_UP
Drug	Mebendazole [31431-39-7]; Down 200; 13.6uM; PC3; HT_HG-U133A	APBB2 HOXA10 ZNF215	9.51e-04	194	23	3	3671_DN
Drug	ST021200; Down 200; 10uM; PC3; HT_HG-U133A	BRCA2 ATAD5 CXCL8	9.66e-04	195	23	3	7493_DN
Drug	pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A	CALD1 CCN1 CXCL8	9.66e-04	195	23	3	5977_DN
Drug	Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; PC3; HT_HG-U133A	CCN1 ATAD5 CXCL8	9.66e-04	195	23	3	5760_UP
Drug	Triflusal [322-79-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A	CCN1 DCLRE1A PARP12	9.66e-04	195	23	3	7451_DN
Drug	Flurandrenolide [1524-88-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A	CALD1 ATAD5 SLC4A4	9.66e-04	195	23	3	6039_UP
Drug	Procarbazine hydrochloride [366-70-1]; Down 200; 15.6uM; HL60; HT_HG-U133A	HOXA10 ZNF215 SLC4A4	9.66e-04	195	23	3	2971_DN
Drug	Primaquine diphosphate [63-45-6]; Up 200; 8.8uM; MCF7; HT_HG-U133A	CALD1 CCN1 SLC4A4	9.66e-04	195	23	3	4845_UP
Drug	5151277; Up 200; 14uM; MCF7; HT_HG-U133A_EA	APBB2 ATAD5 PARP12	9.66e-04	195	23	3	903_UP
Drug	Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; PC3; HT_HG-U133A	CALD1 BRCA2 SLC4A4	9.66e-04	195	23	3	5763_DN
Drug	Nizatidine [76963-41-2]; Down 200; 12uM; HL60; HT_HG-U133A	APBB2 HOXD10 HOXA10	9.66e-04	195	23	3	3047_DN
Drug	Ioxaglic acid [59017-64-0]; Down 200; 3.2uM; HL60; HT_HG-U133A	APBB2 ZNF215 SLC4A4	9.66e-04	195	23	3	2966_DN
Drug	Trimeprazine tartrate [4330-99-8]; Up 200; 5.4uM; HL60; HT_HG-U133A	CCN1 HOXD10 SLC4A4	9.66e-04	195	23	3	2736_UP
Disease	Rheumatoid Arthritis	CALD1 CCN1 HOXD10 CXCL8	9.48e-06	174	23	4	C0003873
Disease	azoospermia (implicated_via_orthology)	NDST4 NDST3	2.02e-04	27	23	2	DOID:14227 (implicated_via_orthology)
Disease	level of Sphingomyelin (d42:2) in blood serum	CXCL8 SLC4A4	2.33e-04	29	23	2	OBA_2045183
Disease	level of Sphingomyelin (d38:1) in blood serum	CXCL8 SLC4A4	2.49e-04	30	23	2	OBA_2045180
Disease	level of Sphingomyelin (d40:1) in blood serum	CXCL8 SLC4A4	2.84e-04	32	23	2	OBA_2045182
Disease	high grade glioma (is_implicated_in)	CCN1 BRCA2	4.91e-04	42	23	2	DOID:3070 (is_implicated_in)
Disease	Endometrial Neoplasms	HOXA10 CXCL8	9.36e-04	58	23	2	C0014170
Disease	neutrophil percentage of leukocytes	ATAD5 ZNF366 ZBTB38 CXCL8	1.17e-03	610	23	4	EFO_0007990
Disease	Endometrial Carcinoma	HOXA10 CXCL8	1.44e-03	72	23	2	C0476089
Disease	intellectual disability (implicated_via_orthology)	NDST4 NDST3	1.56e-03	75	23	2	DOID:1059 (implicated_via_orthology)
Disease	Pancreatic Neoplasm	BRCA2 CXCL8	2.75e-03	100	23	2	C0030297
Disease	Malignant neoplasm of pancreas	BRCA2 CXCL8	2.86e-03	102	23	2	C0346647
Disease	C-X-C motif chemokine 10 measurement	CXCL8 SLC4A4	3.25e-03	109	23	2	EFO_0008056
Disease	cancer	BRCA2 ATAD5 ZBTB38	3.58e-03	400	23	3	MONDO_0004992
Disease	Adenocarcinoma	HOXA10 CXCL8	3.67e-03	116	23	2	C0001418
Disease	Carcinoma, Granular Cell	HOXA10 CXCL8	3.67e-03	116	23	2	C0205644
Disease	Adenocarcinoma, Tubular	HOXA10 CXCL8	3.67e-03	116	23	2	C0205645
Disease	Adenocarcinoma, Oxyphilic	HOXA10 CXCL8	3.67e-03	116	23	2	C0205642
Disease	Carcinoma, Cribriform	HOXA10 CXCL8	3.67e-03	116	23	2	C0205643
Disease	Adenocarcinoma, Basal Cell	HOXA10 CXCL8	3.67e-03	116	23	2	C0205641

Protein segments in the cluster

Peptide	Gene	Start	Entry
YYIGKSPKKISSPKK	ATAD5	1196	Q96QE3
TCYKTAPGKIEKVKP	AKAP2	761	Q9Y2D5
KSPCSSSRFTKKKPL	CCDC116	401	Q8IYX3
TETKNSTPPKCRKKY	APBB2	56	Q92870
CSKTKKSPEPVRFTY	CCN1	286	O00622
FYPKSFKSKKQKPSR	ANKRD12	406	Q6UB98
KTKCLGKSKGRKYPP	NDST3	816	O95803
VPKYSKFSKPTCFLL	IFNLR1	206	Q8IU57
LTAKSGRKKRCPYTK	HOXA10	331	P31260
TKCLGKSKGRKYPPM	NDST4	816	Q9H3R1
GTTKKVCRRPKYVSP	PARP12	451	Q9H0J9
PRSCGTKYETPIKKK	BRCA2	3301	P51587
LTAKSGRKKRCPYTK	HOXD10	261	P28358
SPKKVDCSIYKKYPV	SPINK7	26	P58062
PKFYNKLKICSLKPK	HCAR1	286	Q9BXC0
SRKKTCPFYKKIPGT	DCLRE1A	696	Q6PJP8
PGKCKYKPVPVRTKS	HHIPL2	606	Q6UWX4
PGSRSPKFKSSKKCL	RIF1	2261	Q5UIP0
KKPFKCFTPKGSSLK	CALD1	631	Q05682
KPFKCLYCPSKFTLK	ZNF366	531	Q8N895
PSRKGSPKCDKFKTY	ZNF215	326	Q9UL58
KKFKTSPYFPTTARK	SLC4A4	711	Q9Y6R1
LAAKPKTCRKPKTFS	ZBTB38	256	Q8NAP3
CIKTYSKPFHPKFIK	CXCL8	36	P10145